Search research articles
Contact Us
Filters
Showing results (61-70 of 416) with videos related to
Page
of 42
Sort By:
Journal of Gastroenterology
|
March 2, 2002
Propranolol ameliorates thrombocytopenia in patients with cirrhosis
Kenji Sakai, Tadashi Iwao, Kazuhiko Oho, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 22, 2004
Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan
Yumiko Nagao, Kazuo Tanaka, Kaoru Kobayashi, et al.
International Journal of Molecular Medicine
|
April 6, 2006
Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study
Kazuo Tanaka, Yumiko Nagao, Tatsuya Ide, et al.
Case Reports in Gastroenterology
|
November 28, 2012
Valine, a branched-chain amino Acid, reduced HCV viral load and led to eradication of HCV by interferon therapy in a decompensated cirrhotic patient
Takumi Kawaguchi, Takuji Torimura, Akio Takata, et al.
International Journal of Molecular Medicine
|
May 29, 2008
HBV and HCV infection in Japanese dental care workers
Yumiko Nagao, Hisako Matsuoka, Takumi Kawaguchi, et al.
International Journal of Molecular Medicine
|
January 14, 2005
Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C
Yumiko Nagao, Takumi Kawaguchi, Tatuya Ide, et al.
Hepato-Gastroenterology
|
November 8, 2006
Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH)
Nozomi Sasaki, Takato Ueno, Yasuyo Morita, et al.
International Journal of Molecular Medicine
|
October 10, 2002
Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B
Shinichiro Hanada, Ryukichi Kumashiro, Ryohei Kaji, et al.
Current Pharmaceutical Design
|
June 13, 2009
Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease
Keiichi Mitsuyama, Hiroshi Yamasaki, Kotaro Kuwaki, et al.
Gastroenterology
|
August 2, 2003
The prognosis for life in an HCV hyperendemic area
Yumiko Nagao, Kunitaka Fukuizumi, Ryukichi Kumashiro, et al.
Page
of 42
Search research articles
Search
Showing results (61-70 of 416) with videos related to
Sort By:
Page
of 42
Journal of Gastroenterology
|
March 2, 2002
Propranolol ameliorates thrombocytopenia in patients with cirrhosis
Kenji Sakai, Tadashi Iwao, Kazuhiko Oho, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 22, 2004
Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan
Yumiko Nagao, Kazuo Tanaka, Kaoru Kobayashi, et al.
International Journal of Molecular Medicine
|
April 6, 2006
Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study
Kazuo Tanaka, Yumiko Nagao, Tatsuya Ide, et al.
Case Reports in Gastroenterology
|
November 28, 2012
Valine, a branched-chain amino Acid, reduced HCV viral load and led to eradication of HCV by interferon therapy in a decompensated cirrhotic patient
Takumi Kawaguchi, Takuji Torimura, Akio Takata, et al.
International Journal of Molecular Medicine
|
May 29, 2008
HBV and HCV infection in Japanese dental care workers
Yumiko Nagao, Hisako Matsuoka, Takumi Kawaguchi, et al.
International Journal of Molecular Medicine
|
January 14, 2005
Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C
Yumiko Nagao, Takumi Kawaguchi, Tatuya Ide, et al.
Hepato-Gastroenterology
|
November 8, 2006
Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH)
Nozomi Sasaki, Takato Ueno, Yasuyo Morita, et al.
International Journal of Molecular Medicine
|
October 10, 2002
Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B
Shinichiro Hanada, Ryukichi Kumashiro, Ryohei Kaji, et al.
Current Pharmaceutical Design
|
June 13, 2009
Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease
Keiichi Mitsuyama, Hiroshi Yamasaki, Kotaro Kuwaki, et al.
Gastroenterology
|
August 2, 2003
The prognosis for life in an HCV hyperendemic area
Yumiko Nagao, Kunitaka Fukuizumi, Ryukichi Kumashiro, et al.
Page
of 42